Long-Term Results of the North American Phase II taTME Multicenter Trial for Rectal Cancer
Three-year outcomes of this multicenter trial support the safety and efficacy of taTME in resectable mid and low rectal tumors, with outcomes comparable to contemporary studies. Longer term oncologic and functional outcomes are needed.
Authors
- Marks Jh
- Antoinette Bonaccorso
- Alison Ricardo
- Alessio Pigazzi (ORCID: https://orcid.org/0000-0003-1088-595X)
- Sami A. Chadi (ORCID: https://orcid.org/0000-0002-2090-8994)
- Lisa Avery (ORCID: https://orcid.org/0000-0002-8431-5143)
- Justin A. Maykel (ORCID: https://orcid.org/0000-0001-9995-1647)
- Heather Carmichael (ORCID: https://orcid.org/0000-0002-0569-8247)
- Sherief Shawki
- Dana R. Sands
- P. Sylla
- Mark Whiteford
- Scott Steele
- Steven Wexner
- Katherine F. Donovan
- Matthew Albert
- Elisabeth C. McLemore
- Karen Zaghiyan
- Karim Alavi
- Teresa DeBeche-Adams
Institutions
- Cedars-Sinai Medical Center (US)
- UMass Memorial Health Care (US)
- Cleveland Clinic (US)
- University Health Network (CA)
- Mayo Clinic (US)
- Humanitas University (IT)
- Georgetown University (US)
- University of Toronto (CA)
- AdventHealth Orlando (US)
- WinnMed (US)
- Lankenau Medical Center (US)
- MedStar Georgetown University Hospital (US)
- Princess Margaret Cancer Centre (CA)
- Mount Sinai Hospital (US)
- Oregon Clinic (US)
- Cleveland Clinic Florida (US)
- Kaiser Permanente West Los Angeles Medical Center (US)
- UMass Memorial Medical Center (US)
- IRCCS Humanitas Research Hospital (IT)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1097/sla.0000000000007044
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00